Bugas, Mary Jane M.

HRN: 09-53-66  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2025
AMPICILLIN 1GM (VIAL)
07/25/2025
07/26/2025
IVTT
2g
Q6h
RBOW
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: